Takeda Pharmaceutical Company Limited (NYSE:TAK) Shares Bought by Vestmark Advisory Solutions Inc.

Vestmark Advisory Solutions Inc. increased its position in Takeda Pharmaceutical Company Limited (NYSE:TAK) by 2.0% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 64,920 shares of the company’s stock after acquiring an additional 1,290 shares during the period. Vestmark Advisory Solutions Inc.’s holdings in Takeda Pharmaceutical were worth $926,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of the company. SG Americas Securities LLC lifted its stake in shares of Takeda Pharmaceutical by 73.1% during the 3rd quarter. SG Americas Securities LLC now owns 16,043 shares of the company’s stock worth $248,000 after purchasing an additional 6,775 shares during the period. Cambridge Investment Research Advisors Inc. lifted its position in Takeda Pharmaceutical by 5.7% during the third quarter. Cambridge Investment Research Advisors Inc. now owns 16,433 shares of the company’s stock worth $254,000 after buying an additional 883 shares during the period. Advisor Partners II LLC boosted its stake in Takeda Pharmaceutical by 19.0% in the 3rd quarter. Advisor Partners II LLC now owns 80,100 shares of the company’s stock worth $1,239,000 after buying an additional 12,802 shares during the last quarter. Park Avenue Securities LLC grew its holdings in Takeda Pharmaceutical by 37.7% in the 3rd quarter. Park Avenue Securities LLC now owns 37,477 shares of the company’s stock valued at $580,000 after buying an additional 10,255 shares during the period. Finally, Sage Rhino Capital LLC increased its stake in shares of Takeda Pharmaceutical by 7.6% during the 3rd quarter. Sage Rhino Capital LLC now owns 11,751 shares of the company’s stock valued at $182,000 after acquiring an additional 831 shares during the last quarter. Hedge funds and other institutional investors own 9.17% of the company’s stock.

Takeda Pharmaceutical Trading Up 0.1 %

Shares of TAK stock traded up $0.01 during trading hours on Monday, hitting $13.38. 121,386 shares of the company were exchanged, compared to its average volume of 1,766,089. The firm has a market cap of $42.35 billion, a PE ratio of 20.26, a PEG ratio of 3.05 and a beta of 0.56. The firm has a fifty day moving average of $13.91 and a 200 day moving average of $14.12. Takeda Pharmaceutical Company Limited has a 1 year low of $13.01 and a 1 year high of $17.11. The company has a quick ratio of 0.55, a current ratio of 1.06 and a debt-to-equity ratio of 0.64.

Takeda Pharmaceutical (NYSE:TAK) last issued its earnings results on Thursday, February 1st. The company reported $0.51 earnings per share for the quarter. Takeda Pharmaceutical had a return on equity of 12.57% and a net margin of 6.90%. The business had revenue of $7.52 billion for the quarter. Analysts expect that Takeda Pharmaceutical Company Limited will post 1.5 earnings per share for the current year.

Takeda Pharmaceutical Company Profile

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience.